Moderna said Friday that Pfizer and BioNTech's vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.
The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.
The survey suggests that one-quarter of respondents were experiencing severe or moderate anxiety and almost half of the respondents were struggling with depression.